Pacylex Pharmaceuticals Inc

$158,000.00 CAD

≈ 2 Canadians' average pay for a year
Department
National Research Council Canada
Program
Industrial Research Assistance Program – Contributions to Firms
Recipient country
Canada
Fiscal year
2016-2017
Agreement period
January 1, 2017 – December 31, 2018
Reference
nrc-cnrc:172-2018-2019-Q2-878946

Published purpose

Pacylex has discovered a biomarker that is lower in certain cancers than normal tissue and that confers sensitivity to our drug. With extensive proof-of-efficacies on our precision medicine strategy in vitro and in vivo in hand, this project enables the next steps of animal safety testing of our lead drug PCLX-001 and further mechanism of action studies to enable an investigative new drug (IND) Health Canada filing so we can eventually start Phase I trials, ideally in Edmonton, AB, Canada.

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful
View official source record Imported July 30, 2026 from open.canada.ca Grants & Contributions